About: Melanoma Institute Australia

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Melanoma Institute Australia Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

Australian non-prifit

Attributes	Values
rdf:type	Item
description	australische Non-Profit-Organisation (de) Australian non-prifit (en)
rdfs:label	Melanoma Institute Australia (en)
skos:prefLabel	Melanoma Institute Australia (en)
name	Melanoma Institute Australia (en)
Freebase ID	wds:Q19875521-49E3344E-EB19-4999-84B6-6C1FB3CD16EC
Freebase ID	/m/012c5zj7
ROR ID	wds:Q19875521-5D4F17AA-2B3B-4D3E-B76B-B4049489D3AA
ROR ID	02jxrhq31
instance of	wds:Q19875521-0afd1450-4e21-55ca-35ab-34a97cd3fc65 wds:Q19875521-5d7cc9a4-4b33-c573-fc26-b0f9cec0ef2d wds:Q19875521-b33d5c45-422c-a135-57ef-5f69eba19697
instance of	nonprofit organization medical organization health charity
country	wds:Q19875521-5e5f7c40-4a77-ee41-1ab3-b83334a9a40f
country	Australia
interested in	wds:Q19875521-2b5c4f26-4aaa-48b5-fba4-994d39890f81
Ringgold ID	wds:Q19875521-28CA0182-6B49-4D52-AEFB-1C2D7A005451
interested in	melanoma
Ringgold ID	213551
located in the adm...erritorial entity	wds:Q19875521-FA333F38-CFD2-4BD1-B3C9-3134232D3578
X username	wds:Q19875521-2DF30A78-7C71-4266-9A17-DFBF7D253A1C
ISNI	wds:Q19875521-9024F91E-D605-48FB-AF5B-54579A8F83A8
official website	wds:Q19875521-f6f5b37a-4151-4051-42ae-bdb4908fb8af
located in the adm...erritorial entity	Sydney
X username	melanomaaus
ISNI	0000000404916278
official website	http://www.melanoma.org.au
GRID ID	wds:Q19875521-ED1FB191-B903-440F-B451-FB8055EA7F3E
GRID ID	grid.419690.3
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q19875521 Melanoma Institute Australia
is research site of	Study of Nivolumab (BMS-936558) Compared With Dacarbazine in Untreated, Unresectable, or Metastatic Melanoma An Investigational Immuno-therapy Study of BMS-986205 Given in Combination With Nivolumab and in Combination With Both Nivolumab and Ipilimumab in Cancers That Are Advanced or Have Spread A Phase IB Study To Evaluate Safety And Therapeutic Activity Of RO6874281, An Immunocytokine, Consisting Of Interleukin-2 Variant Targeting Fibroblast Activation Protein-Α, In Combination With Pembrolizumab (Anti-Pd-1), In Participants With Prev Radiotherapy or Imiquimod in Complex Lentigo Maligna Pembrolizumab Plus Epacadostat, Pembrolizumab Monotherapy, and the EXTREME Regimen in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (KEYNOTE-669/ECHO-304) A Study to Evaluate Neoadjuvant Sonidegib Followed by Surgery or Imiquimod in the Management of Basal Cell Carcinoma Neoadjuvant Dabrafenib + Trametinib for AJCC Stage IIIB-C BRAF V600 Mutation Positive Melanoma Anti‐PD 1 Brain Collaboration for Patients With Melanoma Brain Metastases A Safety and Efficacy Study of Multiple Administration Regimens for Nivolumab Plus Ipilimumab in Subjects With Melanoma Neoadjuvant Dabrafenib, Trametinib and/or Pembrolizumab in BRAF Mutant Resectable Stage III Melanoma Expanded Access Protocol for PV-10 for Cutaneous or Subcutaneous Tumors Molecular Profiling and Matched Targeted Therapy for Patients With Metastatic Melanoma Cobimetinib (Targeted Therapy) Plus Atezolizumab (Immunotherapy) in Participants With Advanced Melanoma Whose Cancer Has Worsened During or After Treatment With Previous Immunotherapy and Atezolizumab Monotherapy in Participants With Previously Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma A Study of Vemurafenib Adjuvant Therapy in Participants With Surgically Resected Cutaneous BRAF-Mutant Melanoma A Study Of Avelumab In Combination With Other Cancer Immunotherapies In Advanced Malignancies (JAVELIN Medley) An Investigational Immuno-therapy Study of BMS-986205 Combined With Nivolumab, Compared to Nivolumab by Itself, in Patients With Advanced Melanoma Anti-PD 1 Brain Collaboration + Radiotherapy (ABC-X Study) A Study Comparing Vemurafenib Versus Vemurafenib Plus Cobimetinib in Participants With Metastatic Melanoma A Study of Vemurafenib in Participants With Metastatic Melanoma An Investigational Immuno-therapy Study to Assess the Safety, Tolerability and Effectiveness of Anti-LAG-3 With and Without Anti-PD-1 in the Treatment of Solid Tumors A Research Study of Patient-led Surveillance Compared to Clinician-led Surveillance in People Treated for Localised Melanoma. A Study of Relatlimab Plus Nivolumab Versus Nivolumab Alone in Participants With Advanced Melanoma Multicenter Selective Lymphadenectomy Trial II (MSLT-II)
is research site of	wds:Q65373447-1ACBEF76-CD3A-4C0A-85C2-68D05CF7BE8F wds:Q64123116-51E17981-5C5A-4D40-92BB-B81E17A0B578 wds:Q64150212-1318023B-6BBE-4001-817F-8B4437FE255D wds:Q64375499-052A9BCA-5493-45BB-B92E-B5B042AC4124 wds:Q64807799-BFD5415E-5135-46CE-9C12-8C69EDFC9497 wds:Q62814719-221D7045-A593-4CCE-8F27-759ACADC6A61 wds:Q61975209-D29DAFA2-749F-4837-ABD2-ABE3110E7334 wds:Q58407589-EE22EEE8-C30F-4778-B87C-E1308AE9A706 wds:Q66082151-689CECF6-2D2A-4787-A420-A641F8B86FDB wds:Q63813252-49F58165-0920-4B76-B882-8A2D5EFF9DC6 wds:Q63817451-7E34DBD1-7FFA-4A38-856F-26E74B50AA1F wds:Q64187129-42C68693-58CB-4EE0-9CDB-F8AAD7CFCB6D wds:Q66042791-09C09494-BD66-4EE3-8155-053574241DFB wds:Q64792435-89DF22ED-7C15-4ADE-9191-B4F5EC182B9B wds:Q64139653-39A0706F-7740-4F37-B27E-71E928D6A0B2 wds:Q65331049-CB55D2DD-2760-41DD-B42E-885D717D734B wds:Q63533926-2FABA736-87AB-4F07-9A6F-94E2A14FD383 wds:Q64173540-575701B3-66FD-47CC-ADBC-7ECEC7C43A95 wds:Q64183457-133FBEA8-4A43-44C5-962C-75723CE127D6 wds:Q63813762-CC86F889-CFCF-47E3-A898-245A41FCBC91 wds:Q61975539-A7CFC32F-D72D-44ED-9414-AA3AF26EEC00 wds:Q64795086-4E473B47-C0CC-4F57-AF22-9396D9678CDD wds:Q64122492-DB6367FF-2ECB-45CB-B37F-89F65DEA0D59 wds:Q65537846-D2215652-3904-4B51-B578-325FEF5D576E
is employer of	Georgina V. Long Richard Scolyer Ricardo De Paoli-Iseppi Serigne Lo James S Wilmott Alexander M Menzies John F Thompson Alexander C.J. van Akkooi Marc D Moncrieff Jenny H J Lee Matteo Carlino Pascale Guitera Valerie Jakrot Jonathan Stretch Kerwin F Shannon Camelia Quek Tuba N Gide Annette Hougaard Chakera

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software